NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

@article{Akcakanat2004NYESO1EA,
  title={NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer},
  author={Argun Akcakanat and Tatsuo Kanda and Yu Koyama and Michitoshi Watanabe and Eiji Kimura and Yutaka Yoshida and Shintarou Komukai and Satoru Nakagawa and Shoji Odani and Hiroshi Fujii and Katsuyoshi Hatakeyama},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2004},
  volume={54},
  pages={95-100}
}
PurposeNY-ESO-1, a member of the cancer/testis antigen (CTA) family, elicits humoral and cellular immune responses in patients with advanced cancer. Unresectable or metastatic esophageal carcinoma patients do not benefit from the present multimodality treatment regimens in terms of survival. The objectives of this study were to analyze the antibody response to NY-ESO-1 antigen in patients with esophageal cancer and to determine the potential of NY-ESO-1 for use in tumor-specific immunotherapy… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Immunomic analysis of human sarcoma.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2003
VIEW 1 EXCERPT

[Expression of NY-ESO-1 gene in human esophageal carcinoma and its cloning].

  • Ai zheng = Aizheng = Chinese journal of cancer
  • 2002
VIEW 3 EXCERPTS